John B. Sanfilippo & Son, Inc.
JBSS
Jodie situation report
John B. Sanfilippo & Son, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 13 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.
- JBSS's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if JBSS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind JBSS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
DNLIDenali Therapeutics Inc. Common StockpartnerNov 6, 2025 ▾
“Ou r clinical programs are as follows: • Tividenofusp alfa (DNL310, ETV:IDS), composed of iduronate-2-sulfatase ("IDS") fused to TV, is designed to deliver IDS into cells and tissues throughout the body, including the brain by crossing the BBB, with the goal…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
JBSS is currently a Follower in the organic co-movement group Retail REITs and Essentials. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for JBSS; it is not active in the latest market snapshot.